Supplier News

  1. New 50 Microliter Electronic Pipettes
    1/12/2015

    INTEGRA has expanded its popular VIAFLO II electronic pipette range. Often requested by users of PCR applications, the new 50 µl models perfectly fill the gap between the 0.5-12.5 µl and  5-125 µl ranges.

  2. Powerful Evaporator For Drug Discovery
    12/18/2013

    The HT-4X centrifugal evaporator from Genevac provides optimised sample preparation capabilities for scientists working in the drug discovery environment

  3. Capsugel Expands Global Manufacturing For Finished Dosage Forms
    9/19/2013

    Capsugel’s Dosage Form Solutions (DFS) business unit unveiled extensive upgrades and expansions to three of its manufacturing facilities in the United States and Europe, deepening the company’s finished dosage form capabilities as part of its LIPIDEX technology platform.

  4. CAMO Releases New Version Of The Unscrambler® X Multivariate Data Analysis And Design Of Experiments Software
    5/2/2013

    As global demand for the commercial and practical insights provided by intelligent processing and analysis of large data sets continues to gather pace, CAMO Software has launched a new version of its all-in-one Multivariate Data Analysis (MVA) and Design of Experiments (DoE) software, The Unscrambler® X.

  5. Leading Vaccine Manufacturer Boosts IT Efficiency And Reduces TCO By 20%
    1/8/2013

    EMC Corporation recently announced that Sanofi Pasteur, a world leading vaccine manufacturer producing more than 1 billion doses of vaccine per year, has deployed EMC® Documentum® D2, enabling the company to accelerate time-to-value through the power of configuration.

  6. Powerful Multivariate Data Analysis Software Enables Engineers, Scientists And Data Analysts To Better Understand Complex Data
    11/14/2012

    CAMO Software is running a year-end campaign on their leading multivariate data analysis software, The Unscrambler X.

  7. SCYNEXIS’ Oral SCY-635 Shows Potential As An Immune Acting Antiviral To Augment Current HCV Treatments
    11/11/2012

    SCYNEXIS, Inc. announced recently the results of a Phase 2a study of lead candidate SCY-635 in combination with pegylated interferon and ribavirin (Peg-IFN/RBV) for the treatment of the hepatitis C virus (HCV)that showed SCY-635 has the potential to play an important role in the reversal of immune exhaustion, restoring the immune systems ofdifficult to treatpatients with HCV.

  8. Marken Prepared For Growth In China
    10/2/2012

    Marken announced recently that it continues its expansion in China to meet the anticipated need for increased clinical trials logistics services.

  9. Pittcon 2013 Announces Short Course Program
    9/30/2012

    The Pittcon Organizing Committee is pleased to announce the listing for the 2013 Short Course program which runs March 16 through March 21, 2013. Short Courses are taught by industry experts; range from half-day up to two-day classes; and include beginner, intermediate, and advanced level curricula.

  10. Wes Wheeler, Marken CEO, Speaks About Marken Expansion
    9/27/2012

    Marken passed an important milestone on 20 August 2012. With the launch of two new pharmaceutical depots, one in Germany and one in New York, the organisation successfully completed phase I of its global depot network plan.